OUR EDITORIAL TEAM

DR. BRUCE CARR

Dr. Carr attended the University of Michigan, College of Liberal Science and Arts and graduated with a B.S. in 1967 and received his M.D. degree from the University of Michigan Medical School in 1971.  He completed a residency in Obstetrics and Gynecology at the University of Texas Southwestern Medical School and Parkland Memorial Hospital in 1975.  Following a few years in the military, he completed a fellowship in Reproductive Endocrinology in 1980 at the University of Texas Southwestern Medical Center.  He joined the faculty in 1980 and became an Associate Professor with tenure in 1984 and full professor in 1988.  Since 1989, he has held the Paul C. MacDonald Distinguished Chair in Obstetrics and Gynecology at the University of Texas Southwestern Medical Center.  He was Director of the Division of Reproductive Endocrinology and Infertility from 1986-2005 and currently the Fellowship Director of Reproductive Endocrinology and Infertility.

As Director of the fellowship training program, Dr. Carr has trained 33 fellows since 1986.  All 33 fellows have passed their written boards in Reproductive Endocrinology.  Many of these fellows have gone on to impressive academic positions.  Dr. Carr has been very active in research, both basic science and clinical.  Dr. Carr currently is a P.I. or co-investigator on three NIH grants and has conducted 60 clinical pharmaceutical trials since 1986. His current areas of research include:  Regulation of steroid metabolism in the human ovary, GnRH agonists, androgen excess, uterine leiomyoma, infertility and the menopause.  Dr. Carr is the author of more than 580 scientific publications and abstracts and is the editor of the Textbook of Reproductive Medicine and Essential Reproductive Medicine and section editor of Endotext.org   He is currently the editor and chief of  Seminars in Reproductive Medicine.  He has received a number of SGI Presenter’s Awards and prize papers for the American Society of Reproductive Medicine.  He has served on the NIH Reproductive Endocrinology section and served as Chairman of the study section.  He has been a Board Examiner with the American Board of Obstetrics and Gynecology since 1984 and a Reproductive Endocrinology subspecialty examiner since 1989, and was Director of the Division of Reproductive Endocrinology and Infertility of the American Board of Obstetrics and Gynecology 2005-2008.  Dr. Carr is currently President of the Society of Reproductive Endocrinology and Infertility (SREI).  Dr. Carr is currently on the Executive Board for ACOG 2008-2010, and ASRM Executive Board 2008-2009.

DR GEORGE P CHROUSOS, MD, MACP,MACE, FRCP (LONDON)

Dr. Chrousos is Professor and Chairman of the First

Department of Pediatrics, University of Athens Medical School, Athens, Greece, and Scientist Emeritus of the National Institute of Child Health and Human Development (NICHD), NIH, Bethesda, MD. He was born and raised in Patras, Greece, and studied Medicine at the University of Athens Medical School, from which he graduated as the valedictorian of his class in 1975. He completed his Doctorate thesis at the University of Athens and did his residency in Pediatrics at New York University Medical School, New York, NY, and his fellowship in Endocrinology at the Clinical Center of the National Institutes of Health, Bethesda, Maryland. Before his return to Greece, Dr. Chrousos was consecutively Senior Investigator, Head of the Pediatric Endocrinology Section and Training Program, and Chief of the Pediatric and Reproductive Endocrinology Branch of the NICHD. During his time at the NIH, Dr. Chrousos also held the position of Clinical Professor of Pediatrics, Physiology and Biophysics at Georgetown University Medical School. Since he gained scientific independence in 1981, Dr. Chrousos has uninterruptedly produced outstanding quality biomedical research on both sides of the Atlantic Ocean. His work has led to improved understanding of the physiology and pathophysiology of the stress response at the neuroendocrine, cellular and molecular levels. He has also advanced the study of hypothalamic-pituitary-adrenal axis diseases and has made major contributions to the understanding of nuclear receptor signaling systems. He described the syndrome of glucocorticoid resistance as a disease of the glucocorticoid receptor and subsequently reported the majority of the kindred with this disorder in the world. His work has withstood the test of time, had a broad interdisciplinary following, and is fundamental for the disciplines of Internal Medicine, Pediatrics, Immunology, Reproductive Medicine, Psychiatry, and Psychology, as well as for the basic sciences of Biology and Biochemistry. According to the ISI, Dr. Chrousos is among the most cited clinical and basic investigators in the world (Clinical Medicine and Biology and Biochemistry) and the highest cited clinical Endocrinologist and Pediatrician. He has authored and coauthored more than 1000 scientific publications, has edited 25 books and his work has been cited more than 46,000 times. He has received many national and international awards and prizes and has given many distinguished invited lectures around the world. He is currently the President of the European Society of Clinical Investigation and the Greek College of Pediatrics.

LESLIE J DE GROOT, MD

Dr De Groot trained at Columbia P & S Medical School, and did his Medical Residency at Presbyterian Hospital in NYC) and Massachusetts General Hospital in Boston. He served in the Public Health Service at National Institutes of Health in Bethesda for one year and in Afghanistan for a second year. He subsequently spent 12 years at Harvard and MGH in the Thyroid Study Unit, and directing the Clinical Research Center at MIT. He joined the Department of Medicine at Chicago in 1968. At U of C he was the head of the Thyroid Study Unit, and for many years Head of the Endocrine Section. He joined the Endocrine Division at Brown during 2004-2008, and is now on the faculty of University of Rhode Island, with a laboratory in Providence. Some of the honors received include Presidency of the American Thyroid Association, and Distinguished Service awards from the Endocrine Society and the Thyroid society. Research accomplishments include purification of thyroid peroxidase enzyme responsible for hormone synthesis and identifying it as the target antigen in thyroid autoimmunity, recognition of the Thyroid Hormone Resistance Syndrome and cloning the thyroid hormone receptor genes involved, identification of HLA DRA1*0501 and a CTLA-4 gene variant as important genetic factors in autoimmune thyroid disease, development of an adenoviral vector for therapy of medullary thyroid cancer, and numerous clinical studies on therapy of thyroid cancer and Graves’ disease. His research interests have recently centered on genetic mechanisms promoting auto-immune thyroid disease, definition of T cell epitopes in the TSH-Receptor antigen in Graves’ disease, and the role of regulatory T cells in the etiology of Graves’ disease. Having been a practicing thyroidologist for several decades, the final goal of his research is to use this information to develop methods to combat autoimmune disease in patients.
De Groot has more that four hundred publications, and received the Endocrine Society award as “Distinguished Educator” in 2004. Perhaps his best known publication is the three-volume textbook “ENDOCRINOLOGY” which he edited thru 6 editions over the past 30 years. He is currently committed to the educational possibilities of two web-books he directs,  WWW.ENDOTEXT.ORG  and WWW.THYROIDMANAGER.ORG, which receive over 80,000 hits each day from physicians around the world.

JACK L LEAHY, MD

Chief, Division of Endocrinology, Diabetes, and Metabolism, University of Vermont Medical School, Burlington, Vermont

Editor, Section on DIABETES AND CARBOHYDRATE METABOLISM

ASHLEY GROSSMAN, MD

Ashley Grossman initially graduated with a BA in Psychology and Social Anthropology from the University of London, then entered University College Hospital Medical School in London and took the University Gold Medal in 1975. He also obtained a BSc in Neuroscience. He joined the Department of Endocrinology at St. Bartholomew’s Hospital where he has been for the past 30 years, and where he is currently Professor of Neuroendocrinology at Barts and the London School of Medicine, and Consultant Physician. In 2000 he was appointed a fellow of the Academy of Medical Sciences. He has published over 600 research papers and reviews.
He has a major interest in tumours of the hypothalamo-pituitary axis, especially Cushing’s disease, but his clinical concern and research has expanded increasingly to include broad areas of endocrine oncology, most especially neuroendocrine tumours of all types, including phaeochromocytomas, paragangliomas, adrenocortical cancer, medullary thyroid cancer and hereditary endocrine tumour syndromes. In terms of basic research, he has developed many studies on hypothalamic regulation, eventually exploring the interaction between the hypothalamus and the immune system in terms of cytokines and gaseous neurotransmitters. However, for the last decade he and his group, which has a strong international flavour, have focused on the molecular pathogenesis of pituitary, adrenal and neuroendocrine tumours.
He is immediate Past-President of the European Neuroendocrine Association (ENEA), Chairman of the UKI Neuroendocrine Tumour Society (UKINETS), Chairman of the European Neuroendocrine Society (ENETS) Advisory Board, and a Member of Council of the European Society for Clinical Investigation. . He is past editor of the journal Clinical Endocrinology, on the editorial board of the major textbook De Groot and Jameson’s Endocrinology, is Vice-Chairman of the major on-line textbook Endotext.org, and serves on the editorial boards of many journals. He is married with 6 daughters who occupy most of his time when he is not working.

JEROME HERSHMAN, MD

Jerome M. Hershman, MD, MS, MACP is Distinguished Professor of Medicine at the David Geffen School of Medicine at UCLA, Associate Chief of the Endocrinology and Diabetes Division at the West Los Angeles VA Medical Center and Director of its Endocrine Clinic.  He was the Editor of the journal Thyroid from 1991-2000.  He received a B.S. in chemistry from Northwestern University, a M.S. in chemistry from the California Institute of Technology, and a M.D. from the University of Illinois School of Medicine in Chicago.  He was a resident in internal medicine at Beth Israel Hospital in Boston and the Boston VA Hospital and trained in endocrinology at the New England Medical Center.  Dr. Hershman was a faculty member in the Department of Medicine at Northwestern University for 3 years, then at the University of Alabama in Birmingham for 5 years before moving to UCLA in 1972.  He has authored over 340 research papers in endocrine literature and written more than 100 authoritative book chapters and reviews about thyroid function and disease.  His current research focuses on the molecular biology of thyroid cancer and the management of thyroid diseases.

CHRISTIAN A. KOCH, MD, FACP, FACE.

Dr Koch is Professor of Medicine and Director of the Division of Endocrinology at the University of Mississippi in Jackson, MS, since March 2006. His research and clinical interest areas include the molecular pathogenesis of (neuro)endocrine tumors (pituitary, thyroid, adrenal glands, GEP-NET, multiple endocrine neoplasia syndromes) and endocrine hypertension (pheochromocytoma/paraganglioma, Cushing's syndrome, testosterone deficiency and growth hormone deficiency and excess syndromes).
Dr. Koch was born and raised in Nuremberg (Bavaria/Franconia, Germany) and entered medical school at the Friedrich-Alexander University in Erlangen-Nuremberg after attending the Humanistic part (Latinum, English, and Graecum) of the Neues Gymnasium Nuremberg. He then went on to pursue training in Neurosurgery (Prof. Wassmann at the University of Muenster/Westfalia) and Neurology in Germany before starting residency in Internal Medicine at the Ohio State University in Columbus, OH, USA, under the chairmanship of Prof. EL Mazzaferri. For clinical and research training in endocrinology, Dr. Koch was selected to work at the National Institutes of Health under the guidance of Prof. George P. Chrousos. Dr. Koch's research focus there was the molecular pathogenesis of endocrine tumors including pheochromocytoma and medullary thyroid cancer as well as multiple endocrine neoplasia syndromes and von Hippel Lindau disease. In 2002, Dr. Koch returned to Germany and joined the division of Prof. Ralf Paschke (since 2004 Prof. M. Stumvoll) at the University of Leipzig. From 2003 to 2005, Dr. Koch was Adjunct Associate Professor at the Division of Endocrinology, Georgetown University (Chief: Prof. JG Verbalis). Prof. Koch has mentored several medical students from Leipzig for their M.D. thesis completion before taking on the position as director of the division of endocrinology at the University of Mississippi in Jackson, MS, in 2006. There, Prof. Koch's focus remains translational and multidisciplinary research with questions arising from patient encounters, trying to explain clinical observations by looking at "bench" results to further improve patient care.
Christian A. Koch has published more than 160 peer-reviewed articles, reviews, and book chapters, in addition to numerous abstracts from oral and poster presentations while mentoring medical students, residents, fellows, and junior faculty. He is an Editor for the journal Case Reports in Medicine, Deputy Editor for J Medical Case Reports, Editorial Board Member for Hormone Metabolic Research, J Thyroid Research, and J Clin Endocrinol & Metab (2004-2008), and serves as reviewer for numerous journals including the New England Journal of Medicine, American Journal of Medicine, PNAS, Cancer Research, Endocrinology, Hormones, J Endocrinol Invest, and others.
Dr. Koch has lectured internationally including 4 continents. Amongst others his awards include the Resident Outstanding Teacher Award at Ohio State University in 1997, Young Investigator Award from the American College of Endocrinology (2001), Winner at the International Poster Competition from the American College of Physicians (2003), and Consultant of the Year Award from the University of Mississippi (2008).

ROBERT MCLACHLAN,MD

Professor Robert McLachlan is Director of Clinical Research at Prince Henry's Institute and Consultant Endocrinologist at the Monash Medical Centre in Melbourne, Australia. He is a physician-scientist having obtained a PhD in reproductive medicine from Monash University in 1987 and then he undertook a position as a Visiting Scientist at the
University of Washington, Seattle with Dr William Bremner in 1987-1989. Upon returning to Australia he has developed clinical and research interests in the fields of spermatogenesis, male fertility regulation and androgen physiology. He is Consultant Andrologist to the Monash IVF program with research interests in the genetics of male infertility. He has served as President of the Fertility Society of Australia and as Secretary of the International Society of Andrology, and is currently a consultant to the WHO on male fertility regulation. Since 2006, he has been Director of the Andrology Australia, a Federal Government initiative committed to research and community & professional education in male reproductive health. He has published more than 160 original papers and serves on editorial boards of leading endocrine and andrology journals, and as Editor of the Male Reproduction Section of www.ENDOTEXT.org <http://www.endotext.org/>.

MARIA NEW, MD

Dr. New received her B.A. from Cornell University and her M.D. from the University of Pennsylvania, where she was awarded the Distinguished Graduate Award.
She was Chairman of Pediatrics at Weill Medical College of Cornell University from 1980 to 2002 and Founding Director of its Children’s Clinical Research Center, where she also served as Chief of Pediatric Endocrinology from 1964 to 2002.

Dr. Maria New is Professor of Pediatrics, Professor of Genetics and Genomic Sciences, and Director of the Adrenal Steroid Disorders Program at Mount Sinai School of Medicine in New York City. She is also serving as Associate Dean for Clinical Research at the Florida International University Herbert Wertheim College of Medicine.
Former president of the Endocrine Society, Dr. New has edited or co-edited 12 medical textbooks, published more than 600 peer-reviewed papers, and served as editor-in-chief of the Journal of Clinical Endocrinology and Metabolism. She has trained more than 100 young physicians-scientists who have become chiefs of pediatric endocrinology and leaders in their field.

Her research, clinical work, and teaching has taken her around the world. In 2005 and 2006, she led genetics research expeditions to Siberia in collaboration with the School of Medicine, St. Petersburg University, Russia.

In 2010, she organized and co-chaired the Second World Conference on Sexual Differentiation in collaboration with the International Olympics Committee.
Dr. New’s contribution is recognized in that she is one of the few pediatricians in the National Academy of Sciences. She has received numerous honors including: the Robert H. Williams Distinguished Leadership Award; the Rhone-Poulenc Rorer Clinical Investigator Award from the American Endocrine Society; the University of Pennsylvania Distinguished Graduate Award; the 1996 Dale Medal, the highest award given by the British Endocrine Society; and the 2003 Fred Conrad Koch Award, the highest award given by the American Endocrine Society. In 2010, she received the Van Wyk Prize, the highest award given in pediatric endocrinology.

She has conducted pioneering research in the area of Congenital Adrenal Hyperplasia, a term used to describe a family of monogenic autosomal recessive disorders of steroidogenesis in which enzymatic defects result in impaired synthesis of cortisol by the adrenal cortex. In addition, Dr. New discovered a new form of hypertension, Apparent Mineralocorticoid Excess, which opened a new field of receptor biology. She was also the first to describe Dexamethasone-Suppressible Hyperaldosteronism, another form of low-renin hypertension. In 1999, she reported what may be the first example of transcription factor defect in human beings.

Dr. Maria New is at the forefront as a distinguished scientific researcher in genetics and adrenal disorders and as a dedicated and beloved clinical physician. She is also an outstanding teacher, committed to training physician-scientists who will help children and parents in the years ahead.

ROBERT REBAR, MD

Robert W. Rebar, M.D., is Executive Director of the American Society for Reproductive Medicine in Birmingham, Alabama and Volunteer Clinical Professor in the Department of Obstetrics and Gynecology at the University of Alabama, Birmingham. Dr. Rebar is certified by the American Board of Obstetrics and Gynecology in obstetrics and gynecology and in reproductive endocrinology and infertility.

Dr. Rebar received his M.D. from the University of Michigan in 1972 and from 1972 to 1974 was a resident in obstetrics and gynecology at Parkland Memorial Hospital in Dallas, Texas. He was a Clinical Associate at the Reproduction Research Branch of the National Institute of Child Health and Human Development (1974-1976) before completing his residency in Obstetrics and Gynecology at the University of California at San Diego Medical Center (1976-1978). After his residency, Dr. Rebar continued on at the University of California, San Diego for 6 years (1978-1984), serving as Associate Professor and Director of the Division of Reproductive Endocrinology for 2 of those years.
He was Professor and Head of the Division of Reproductive Endocrinology and Infertility in the Department of Obstetrics and Gynecology at the Northwestern University School of Medicine (1984-1988). Before assuming his current duties, Dr. Rebar was Professor and Chairman of the Department of Obstetrics and Gynecology at the University of Cincinnati College of Medicine from 1988 through 1999 and served as
Associate Executive Director of the American Society for Reproductive Medicine from 2000 through 2002.

Dr. Rebar is a member of numerous professional societies, including the American College of Obstetricians and Gynecologists (Fellow), the Endocrine Society and the Society for Gynecologic Investigation. Dr. Rebar serves on the review boards for several journals, including the New England Journal of Medicine, American Journal of Obstetrics and Gynecology, Fertility and Sterility, Endocrinology, Journal of Clinical Endocrinology and Metabolism, and Obstetrics and Gynecology. He is currently a member of the editorial board for the journals of Contraception, Journal of Reproductive Medicine and Journal Watch. Dr. Rebar has contributed to many books, as well as authored
well over 150 articles on menopause, fertility, and reproductive endocrinology and has been the Principal or a Co-Investigator on several NIH grants.

FREDERICK SINGER, MD

Frederick R. Singer is Director of the Endocrine/Bone Disease Program at the John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, California and is Clinical Professor of Medicine at UCLA School of Medicine.  Dr. Singer is past Chairman of the Board of Directors of the Paget Foundation and past president of the American Society for Bone and Mineral Research.  He has served on many national public health committees, including as chairman of the USPHS FDA Endocrinologic Metabolic Drug Advisory Committee, on NIAMSD ad hoc review groups on osteoporosis, and as co-chairman of the NIAMSD National Research Plan Task Force on Bone Biology and Bone Diseases.  He also was Chairman of the National Cancer Institute Special Study Section on Molecular Interactions Between Tumor Cells and Bone in 2003. Dr. Singer has served on the editorial boards of Calcified Tissue International, Journal of Bone and Mineral Research, Journal of Clinical Endocrinology and Metabolism, and Osteoporosis International, Dr. Singer received his MD degree from the University of California School of Medicine, San Francisco in 1963.  He completed his postgraduate training in internal medicine at the University of California Affiliated Hospitals, Los Angeles, followed by research fellowships in endocrinology at the Royal Postgraduate Medical School, London and the Massachusetts General Hospital, Boston, Massachusetts.  His research interests are skeletal complications of malignancy, Paget’s disease of bone, primary hyperparathyroidism, osteoporosis and the effect of vitamin D on breast cancer.

DACE TRENCE, MD

Dace L. Trence, MD, FACE is currently Director of the Diabetes Care Center and Associate  Professor of Medicine at the University of Washington Medical Center in Seattle. She is also the University of Washington Endocrine Fellowship Program Director and Director of Endocrine Days, a medical education program for endocrinologists practicing in the Pacific Northwest.  She currently serves on the American Association of Clinical Endocrinologists Board of Directors, chairing the AACE CME committee. She has been on the editorial boards of several journals including Clinical Diabetes. She has had articles published in JCEM, JAMA, Diabetes Care and is a co-author of Optimizing Diabetes Care for the Practitioner. Her current interests include improving educational processes in diabetes self management, clinical training of health care professionals, and vitamin D effects on glycemic control.

AARON VINIK, MD

Dr. Vinik has brought international recognition to Virginia as a result of his research and recent discovery of a gene, which could prove to be a cure for diabetes. The gene, INGAP (islet neogenesis associated protein) is responsible, either alone or in combination with other factors, for stimulating immature cells in the diabetic pancreas to produce insulin. When INGAP protein was administered to diabetic hamsters it was shown to reverse diabetes in 40% to 50% of animals. Animal studies were followed by human, multi-center clinical studies in both type 1 and type 2 diabetes, carried out by some of the most highly recognized investigators in the country; the results showed that even in type 1 diabetes an increase in C- peptide, (a measure of islet function), could be induced after 3 months of treatment. In type 2 diabetes, INGAP was able to stimulate an increase in C peptide and reduce HbA1c levels by close to 1%.  Phase 2 clinical trials have been planned as multiple-center, randomized, double-blind, placebo-controlled studies to assess the safety, and efficacy of a new formulation of INGAP peptide given subcutaneously as injections for 12 weeks in adult patients with Type 1 diabetes, who have been treated with insulin for greater than 2 years and who are otherwise in good general health. The study locations for patients will be Montreal, Canada and Rochester, MN.
The discovery of INGAP has far reaching implications: it could free the two million people with type I diabetes from daily injections of insulin; it could help the 20 million people with type 2 diabetes whose pancreas ultimately fails; and, it could be used in genetic screening to identify those predisposed for developing diabetes. The discovery is a result of 16 years of perseverance, committed to the belief (thought by many to be heretical) that islets could be made to grow.

The success in finding the INGAP gene follows years of success in research and treatment of neuropathy, a complication of diabetes.  Dr. Vinik is a national leader in basic and clinical neuropathy. He, in essence, has defined the heterogeneity of neuropathy, established a need for a modular approach depending on the particular nerve fiber damaged, and pioneered studies on the relationship between neuropathy, autoimmunity, and cell toxicity. He also pioneered the use of immunotherapy for autoimmune diabetic neuropathy. He has championed the evaluation of autonomic neuropathy as well as the identification of the site of pathology of diabetic peripheral neuropathy, using contact heat potentials (CHEPS). His advances in the understanding of neuropathy have resulted in patient treatment referrals from all parts of the United States and many other countries. He has been listed amongst the best physicians in USA for the past nine years.

Dr. Vinik has been invited to present his work all over the world. Recognized as a pioneer and a scholar, Dr. Vinik has authored six books, one devoted to islet regeneration, 109 book chapters, and has published more than 450 papers in peer-reviewed, highly reputable journals. He has also published more than 395 abstracts and he and the fellows he has trained have presented scientific papers at innumerable national and international meetings. He has been invited to give the Banting Lecture at the University of Toronto, the Minkowski Lecture in Kaunas, Lithuania, and the "INGAP Story" in Helsingor, Denmark at the International Pancreatic Islet Symposium.  He has been "Meet the Professor" at the Endocrine Society, American Diabetes Association, and American College of Physicians.  Dr. Vinik received the award for the Virginia Outstanding Scientist by the Science Museum of VA, in 2002 and the Southern Medical Association’s Seale Harris Award in 2003. He received the Dean's Award for Outstanding Research in 1993 and the Dean's Award for Outstanding Faculty in 1999.
He was awarded Alpha Omega Alpha in 2004 by students of EVMS. In 2005, he was elected to Mastership of the American College of Physicians.

Dr. Vinik is a member of a number of professional societies including the American Endocrine, Diabetes, Gastroenterology, and the European and International Diabetes associations. Dr. Vinik served as a member of the National Institute of Health General Clinical Research Center Study Section and the NIH Data Management committee. He was also Chairman of the American Diabetes Association task force on Nutrition, which established the guidelines for nutritional management of diabetes, and Chairman of the subcommittee for development of guidelines for neuropathy testing; in addition, he was a member of the committee to develop guidelines for managing lipid disorders in diabetes. He has served previously as Chairperson of the American Diabetes Association Grant Review Committee and as Director of the National Post-Graduate Education Course.

Dr. Vinik’s scholarly pursuits include reviewing scientific manuscripts for many journals. Additionally, he is Editor of “Endocrine Reviews” and Associate Editor of “Diabetes Care;” He is also an editor of several books, such as “Neuroendocrine Tumors” from Interscience Institute; editor of the section on Neuroendocrine Tumors in De Groot’s textbook of Endocrinology; of the section on Neuroendocrine Tumors in the textbook, Cancer Medicine, and co-editor of the textbook, “Controversies in Treating Diabetes.”

Dr Vinik is a featured speaker on diabetic neuropathy in the television series, D-Life, which presents education programs on diabetes to the public.

Dr. Vinik has received research funding for his studies from the National Institutes of Health, the National Cancer Institute, the Kroc Foundation, the American Diabetes Association, HUD, DHHS, NASA, The Diabetes Institutes Foundation, and pharmaceutical industries.

Dr. Vinik holds three issued patents and six more patents are being studied. He holds the copyright for the Norfolk Quality of Life tool, used as an end-point for clinical trials in neuropathy for assessing lifestyle problems in patients with diabetic neuropathy. He also holds the copyright for the questionnaire for assessing Quality of Life in patients with neuroendocrine tumors.

MARTIN O. WEICKERT, MD